BF Biosciences gains DRAP's approval for brownfield expansion

MG News | September 09, 2024 at 11:49 AM GMT+05:00

Add Mettisglobal as a Trusted Source on Google

0:00

September 09, 2024 (MLN): BF Biosciences Limited, a subsidiary of Ferozsons Laboratories Limited (PSX: FEROZ), has secured approval from the Drug Regulatory Authority of Pakistan (DRAP) for its brownfield expansion (Line II).

This expansion includes a pre-filled syringes line, a liquid and lyophilized line, and a product development section.

The commercial production from the pre-filled syringes line has commenced, whereas the liquid & lyophilized line is under internal validation and will start commercial production in the second quarter of FY 2024-25.

Additionally, BF Biosciences Limited has launched Sematide (Semaglutide) in a pre-filled syringe.

Sematide is the first Glucagon-Like Peptide 1 (GLP1) receptor agonist approved for local manufacture in Pakistan, offering a convenient solution for diabetes management.

The pre-filled syringe eliminates dosing errors and is easy to use by the patients.

Sematide is being manufactured at the new state-of-the-art European prefilled syringes line of BF Biosciences Limited.

Copyright Mettis Link News

Related News

Name	Price/Vol	%Chg/NChg
KSE100	177,955.51 511.87M	-1.41% -2546.94
ALLSHR	107,760.09 1,031.65M	-1.33% -1447.05
KSE30	52,861.72 168.23M	-1.67% -899.47
KMI30	250,423.07 172.67M	-1.65% -4194.95
KMIALLSHR	69,064.88 707.35M	-1.58% -1107.48
BKTi	50,927.55 36.18M	-1.64% -850.36
OGTi	35,469.86 14.02M	-2.08% -753.79

Symbol	Bid/Ask	High/Low

Name	Last	High/Low	Chg/%Chg
BITCOIN FUTURES	64,840.00	65,190.00 64,070.00	430.00 0.67%
BRENT CRUDE	91.24	91.85 90.61	0.37 0.41%
RICHARDS BAY COAL MONTHLY	110.00	0.00 0.00	0.50 0.46%
ROTTERDAM COAL MONTHLY	122.70	122.70 122.00	0.45 0.37%
USD RBD PALM OLEIN	1,175.00	1,175.00 1,175.00	0.00 0.00%
CRUDE OIL - WTI	84.26	85.07 83.77	0.52 0.62%
SUGAR #11 WORLD	17.44	17.59 16.89	0.57 3.38%